Humira(CF) pen 40 MG/0.4 MLS
Ended Awarded Last action
- Contract number
- SPE2DR26FV8D3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $38,490
Award facts
- Contract value 100% obligated
- $38,490.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $38,490.20 delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mLs on January 30, 2026, with completion targeted for February 2, 2026. This is a firm fixed-price, non-set-aside contract for pharmaceutical supply to support federal medical procurement needs. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling delivery of a broad range of medications, medical supplies, vaccines, and specialty pharmaceuticals to military healthcare systems and other federal medical institutions worldwide.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical supply needs. The company delivers medications across multiple therapeutic domains to support military treatment facilities, veterans' healthcare programs, and other government healthcare systems. The competitive award demonstrates the contractor's capability to meet federal procurement requirements and reflects its established role as a primary supplier of essential pharmaceutical commodities to the Defense Logistics Agency and Defense Health Agency.
Quick answers
Who was awarded contract SPE2DR26FV8D3?
SPE2DR26FV8D3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26FV8D3 worth?
The government has obligated $38,490 on SPE2DR26FV8D3.
Is contract SPE2DR26FV8D3 an order under another contract?
Yes. SPE2DR26FV8D3 is a delivery order under SPE2DR25D2214, an indefinite delivery contract.
Was contract SPE2DR26FV8D3 competed?
The extent of competition for SPE2DR26FV8D3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award